enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. US FDA approves Amgen drug for small cell lung cancer - AOL

   www.aol.com/news/us-fda-approves-amgen-drug...

   Amgen said the U.S. price for Imdelltra is $31,500 for the first cycle, and $30,000 for subsequent cycles. ... pivotal trial in advanced small cell lung cancer to receive full FDA approval of the ...

3. Obecabtagene autoleucel - Wikipedia

   en.wikipedia.org/wiki/Obecabtagene_autoleucel

   Obecabtagene autoleucel, sold under the brand name Aucatzyl, is an anti-cancer medication used for the treatment of acute lymphoblastic leukemia. [ 1 ] [ 2 ] It is a CD19 -directed genetically modified autologous T-cell immunotherapy.

4. J&J's chemotherapy-free treatment for lung cancer gets US ...

   www.aol.com/news/us-fda-approves-j-js-111733970.html

   (Reuters) -The U.S. Food and Drug Administration on Tuesday approved Johnson & Johnson's chemotherapy-free combination treatment for a type of non-small cell lung cancer, setting up a challenge ...

5. Lifileucel - Wikipedia

   en.wikipedia.org/wiki/Lifileucel

   The US Food and Drug Administration (FDA) approved Lifileucel through the accelerated approval pathway and granted the application orphan drug, regenerative medicine advanced therapy, fast track, and priority review designations under the brand name Amtagvi to Iovance Biotherapeutics. [3]

6. Osimertinib - Wikipedia

   en.wikipedia.org/wiki/Osimertinib

   Osimertinib was designated as a breakthrough therapy in April 2014, based on phase I trial results, [22] and the drug was provisionally approved under the FDA accelerated approval program with a priority review voucher, in November 2015. [23] [10]

7. US FDA approves Pfizer's blood cancer therapy - AOL

   www.aol.com/news/us-fda-approves-pfizers-blood...

   The FDA approval is based on data from a mid-stage study that showed that 58% of patients treated with Pfizer's therapy had no signs of cancer or had seen a significant decrease in cancer cells in ...

8. Selinexor - Wikipedia

   en.wikipedia.org/wiki/Selinexor

   Selinexor sold under the brand name Xpovio among others, is a selective inhibitor of nuclear export used as an anti-cancer medication.It works by blocking the action of exportin 1 [6] and thus blocking the transport of several proteins involved in cancer-cell growth from the cell nucleus to the cytoplasm, which ultimately arrests the cell cycle and leads to apoptosis. [8]

9. US FDA approves BeiGene's esophageal cancer therapy - AOL

   www.aol.com/news/us-fda-approves-beigenes...

   The therapy, branded as Tevimbra, was approved as a monotherapy for adult patients with unresectable or metastatic esophageal squamous cell carcinoma. The American Cancer Society estimates there ...